A Double-Blind, Randomized, Placebo-Controlled, Sequential Group, Single Ascending and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39439335 in Healthy Japanese and Caucasian Adult Male Subjects
Phase of Trial: Phase I
Latest Information Update: 15 Apr 2013
At a glance
- Drugs Mavatrep (Primary)
- Indications Musculoskeletal pain; Pain
- Focus Pharmacokinetics
- 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Nov 2012 Planned number of patients changed from 108 to 84 as reported by ClinicalTrials.gov.